Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ddl who wrote (317)	8/2/2005 4:18:47 PM
From: Pluvia	Read Replies (1) of 377

<<<<<<Wouldn't the FDA have considered that before approval the PIII protocol? not necessiarily. <<<<<<Also, wouldn't Willforth, a past director of the FDA for the Centre for Devices, current director for VAS, have considered this? vsgn has done a good job stacking their bod. unfortunately, that does not translate to efficacy or drug approval. <<<<<<< And what about the top cardiologists on VAS's Advisory board... would they attach their names to something that's trying to sneak in the back door? you can find md's that will say anything if they're paid, look at c evert koop. i think if you actually read vsgn's published PII results you'd see their results are not alarmingly dramatic. <<<<<<And if it works, do you really think the FDA would prevent it's release and push to have VAS start all over again, classified as a drug, when the machine would still be required? that is a distinct possibility. device classification is a loophole to get a drug approved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next